Intravenous Immunoglobulin-Associated Severe Hemolytic Anemia
Authors:
Open Access
- 1 July 2023
- journal article
- research article
- Published by Elmer Press, Inc. in Journal of Medical Cases
- Vol. 14 (7) , 227-231
Abstract
Intravenous Immunoglobulin-Associated Severe Hemolytic AnemiaKeywords
This publication has 22 references indexed in Scilit:
- Adverse effects of immunoglobulin G therapy: thromboembolism and haemolysisClinical and Experimental Immunology, 2014
- Hemolysis in patients with antibody deficiencies on immunoglobulin replacement treatmentTransfusion, 2014
- IVIG — A Hemolytic CulpritNew England Journal of Medicine, 2012
- Hemoglobinuria and Acute Kidney Injury Requiring Hemodialysis Following Intravenous Immunoglobulin InfusionAmerican Journal of Kidney Diseases, 2010
- Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysisTransfusion, 2008
- True hyponatremia secondary to intravenous immunoglobulinClinical and Experimental Nephrology, 2006
- Risks associated with the use of intravenous immunoglobulin 1 1This review article reflects the opinions of the authors and not necessarily those of the U.S. Food and Drug Administration.Transfusion Medicine Reviews, 2003
- Aseptic Meningitis Associated with High-Dose Intravenous Immunoglobulin Therapy: Frequency and Risk FactorsAnnals of Internal Medicine, 1994
- Hemolysis following intravenous immune globulin therapyTransfusion, 1986
- Drug-induced immune hemolytic anemiaThe American Journal of Medicine, 1975